OBJECTIVE: This randomized controlled study of 164 outpatients with bipolar disorder in a community mental health center who receivedstandardized psychoeducation (Life Goals Program [LGP]) or treatment as usual sought to determine whether there were differences between the groups in medication adherence attitudes and behaviors. METHODS: Patients were randomly assigned to treatment as usual (N=80) or treatment as usual plus LGP (N=84) and were assessed at baseline and at the three-, six-, and 12-month follow-up. Primary outcomes were change in score from baseline on the Drug Attitude Inventory (DAI) and on self-reported treatment adherence behaviors (SRTAB). RESULTS: At baseline, there were no significant differences between the two groups. Slightly less than half (N=41, 49%) of the LGP group participated in most or all (four to six) LGP sessions, 14% (N=12) participated in one to three sessions, and 37% (N=31) did not participate in any sessions. At the 12-month follow-up there was improvement among all patients, with no significant differences between the two groups, in DAI scores, SRTAB, symptoms, psychopathology, and functional status. Greater depressive severity at baseline was associated with more negative attitudes toward treatment over time, although this finding was not significant (p=.056). Secondary analysis of persons in the LGP group found that compared with those who did not go to any LGP sessions, those with partial or full participation in LGP sessions had improved attitudes toward medication at the three- and six-month follow-up, but no difference was found between the three LGP subgroups by the 12-month follow-up. CONCLUSIONS: There were no differences between two groups in treatment attitudes at the 12-month follow-up. Low attendance rates mitigated effects on primary outcomes. Effects of LGP may become lost over time without ongoing intervention, and individuals with depression may have reduced response to LGP.
RCT Entities:
OBJECTIVE: This randomized controlled study of 164 outpatients with bipolar disorder in a community mental health center who received standardized psychoeducation (Life Goals Program [LGP]) or treatment as usual sought to determine whether there were differences between the groups in medication adherence attitudes and behaviors. METHODS:Patients were randomly assigned to treatment as usual (N=80) or treatment as usual plus LGP (N=84) and were assessed at baseline and at the three-, six-, and 12-month follow-up. Primary outcomes were change in score from baseline on the Drug Attitude Inventory (DAI) and on self-reported treatment adherence behaviors (SRTAB). RESULTS: At baseline, there were no significant differences between the two groups. Slightly less than half (N=41, 49%) of the LGP group participated in most or all (four to six) LGP sessions, 14% (N=12) participated in one to three sessions, and 37% (N=31) did not participate in any sessions. At the 12-month follow-up there was improvement among all patients, with no significant differences between the two groups, in DAI scores, SRTAB, symptoms, psychopathology, and functional status. Greater depressive severity at baseline was associated with more negative attitudes toward treatment over time, although this finding was not significant (p=.056). Secondary analysis of persons in the LGP group found that compared with those who did not go to any LGP sessions, those with partial or full participation in LGP sessions had improved attitudes toward medication at the three- and six-month follow-up, but no difference was found between the three LGP subgroups by the 12-month follow-up. CONCLUSIONS: There were no differences between two groups in treatment attitudes at the 12-month follow-up. Low attendance rates mitigated effects on primary outcomes. Effects of LGP may become lost over time without ongoing intervention, and individuals with depression may have reduced response to LGP.
Authors: M S Bauer; W O Williford; E E Dawson; H S Akiskal; L Altshuler; C Fye; A Gelenberg; H Glick; B Kinosian; M Sajatovic Journal: J Affect Disord Date: 2001-12 Impact factor: 4.839
Authors: Francesco Colom; Eduard Vieta; Anabel Martinez-Aran; Maria Reinares; Jose Manuel Goikolea; Antonio Benabarre; Carla Torrent; Merce Comes; Barbara Corbella; Gemma Parramon; Josep Corominas Journal: Arch Gen Psychiatry Date: 2003-04
Authors: Amy M Kilbourne; Edward P Post; Agnes Nossek; Elif Sonel; Larry J Drill; Susan Cooley; Mark S Bauer Journal: Bipolar Disord Date: 2008-09 Impact factor: 6.744
Authors: Martha Sajatovic; Debra S Rosch; Harry J Sivec; Dilara Sultana; Douglas A Smith; Samer Alamir; Peter Buckley; C Raymond Bingham Journal: Psychiatr Serv Date: 2002-10 Impact factor: 3.084
Authors: Colin A Depp; Brent Mausbach; Eric Granholm; Veronica Cardenas; Dror Ben-Zeev; Thomas L Patterson; Barry D Lebowitz; Dilip V Jeste Journal: J Nerv Ment Dis Date: 2010-10 Impact factor: 2.254
Authors: Thomas Canales; Samuel Rodman; Danette Conklin; Kaylee Sarna; Martha Sajatovic; Jennifer B Levin Journal: Psychopharmacol Bull Date: 2022-06-27
Authors: Jennifer B Levin; Michelle E Aebi; Molly Howland; Marina Barboza; Logan Eskew; Curtis Tatsuoka; Kristin A Cassidy; Martha Sajatovic Journal: J Nerv Ment Dis Date: 2020-02 Impact factor: 1.899
Authors: Pernille Pedersen; Hans Jørgen Søgaard; Bjarne Frostholm Yde; Merete Labriola; Ellen A Nohr; Chris Jensen Journal: BMC Public Health Date: 2014-12-17 Impact factor: 3.295